RLX Releases Q2 2022 Financial Report on NASDAQ

Sep.21.2022
RLX Releases Q2 2022 Financial Report on NASDAQ
Chinese vaping company, RLX, reported a 12.1% decline in Q2 2022 revenues due to regulatory restrictions on store expansions.

RLX, a Chinese e-cigarette company, released its second-quarter financial report for 2022 on September 21 at 6:00 AM Eastern Time (18:00 Beijing Time) on NASDAQ. Below are the key takeaways compiled by 2FIRSTS.


Net income for the second quarter of 2022 was 2.2339 billion yuan ($333.5 million USD), a 12.1% decrease compared to the same period in 2021, which had a net income of 2.5414 billion yuan.


Reasons for the decrease: The company halted store expansions and new product releases during a transitional period to comply with regulatory requirements. The net profit for the second quarter of 2022, confirmed under the US Generally Accepted Accounting Principles (GAAP), was 441.6 million yuan, a 46.4% decrease compared to the same period in 2021, which saw a net profit of 824.3 million yuan.


The net profit for Q2 2022, unadjusted for GAAP standards, was 634.7 million yuan, a 2.6% decrease compared to 651.8 million yuan in the same period of 2021.


In the second quarter of 2022, the gross profit margin was 43.8%, compared to 45.1% during the same period in 2021.


Reasons for the decline: adjustment of product lines, increase in inventory, and impairment losses incurred in order to comply with regulatory requirements on properties, factories, and equipment.


In the second quarter of 2022, operating costs reached RMB 530.9 million (USD 79.3 million), representing a growth of 217.6% compared to the same period in 2021, where operating costs were RMB 167.2 million. The increase in operating costs was mainly due to a change in equity incentive expenses, with RMB 193.2 million (USD 28.8 million) in Q2 2022, compared to RMB 172.5 million in the same period last year.


In the second quarter of 2022, general and administrative expenses amounted to 290.7 million yuan (approximately 43.4 million US dollars), representing a 531.3% increase from the same period in 2021, which amounted to 46.1 million yuan. The significant increase was primarily due to increased compensation expenses based on stock and higher salaries and benefits.


In the second quarter of 2022, research and development expenses amounted to RMB 117.6 million (USD 17.6 million), compared to RMB 4.9 million in the same period last year. The increase was mainly due to compensation expenses, salary and welfare increases, and consulting fees.


In the second quarter of 2022, the operating revenue was 446.9 million yuan (66.7 million US dollars), a decrease of 54.4% compared to the same period in 2021, when it was 979.3 million yuan. However, interest income increased by double, from 160.7 million yuan in the same period in 2021 to 427.2 million yuan. Investment income also increased nearly twice, from 238.7 million yuan in the same period in 2021 to 406.3 million yuan.


As of the end of the second quarter of 2022, the cash and cash equivalents of the company stood at RMB 1.7091 billion, down 67.2% from the previous year's RMB 5.209 billion. Short-term deposits were RMB 5.315 billion, up 32.1% from the previous year's RMB 4.0221 billion.


As of the end of the second quarter of 2022, the total assets amounted to RMB 17.5163 billion, compared to RMB 16.3651 billion at the end of the previous year. The total liabilities were RMB 2.9084 billion, which is slightly higher than the RMB 2.8464 billion at the end of the previous year. The debt-to-asset ratio decreased from 17.4% at the end of the previous year to 16.6%.


According to the financial report, a subsidiary of Yooz, a Chinese e-cigarette brand, has been awarded a production license by the State Tobacco Monopoly Administration. The production quota for the license includes 15.05 million refillable e-cigarette devices, 328.7 million pod cartridges, and 6.1 million disposable e-cigarettes annually. The license is valid from July 18, 2022, to July 31, 2023.


Statement:


1. This article is intended only for internal industry research and exchange. It does not make any investment or brand recommendations. It is not intended to be used as a basis for any investment decisions. 2. The data and analysis conclusions cited in this article have not been confirmed in writing by the companies referenced. Please refer to the company's official publications for all data.


This article is an original piece created by 2FIRSTS Technology Co., Ltd. of Shenzhen. The copyright and permission to use it belong to the company, and no individual or organization is authorized to commercially reproduce, copy, or use it in any way that infringes upon the company's copyright without prior permission. Any violations of this will result in the company reserving the right to pursue legal action.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target
UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target
London-based vaping company Plxsur, which had claimed in fundraising materials it could reach $1 billion in annual revenue and capture about 10% of the global vaping market, has been sold out of administration for £76,500. Administrators said the figures were aspirational and depended on acquisitions that were never completed, as the company later ran out of cash and entered insolvency, with a shareholder ultimately buying the business.
Jan.22 by 2FIRSTS.ai
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai
Exclusive | China Releases E-Cigarette Regulatory “Status Report”, First Comprehensive Disclosure of Oversight Framework and International Cooperation
Exclusive | China Releases E-Cigarette Regulatory “Status Report”, First Comprehensive Disclosure of Oversight Framework and International Cooperation
As 2025 draws to a close, China’s State Tobacco Monopoly Administration has released a white paper–style “Status Report” on e-cigarette regulation, systematically outlining its oversight framework, enforcement outcomes and international cooperation. 2Firsts provides exclusive in-depth reporting and analysis, offering insight into China’s regulatory logic and governance direction.
Dec.29 by 2Firsts Perspectives
PMI AI White Paper Warns of “Cognitive Atrophy” and Attention Erosion, Calls for Focus on Human Cognition’s Evolution
PMI AI White Paper Warns of “Cognitive Atrophy” and Attention Erosion, Calls for Focus on Human Cognition’s Evolution
Philip Morris International (PMI) has released a white paper calling for cross-sector dialogue on how AI may affect human cognitive abilities. The paper flags risks including “cognitive atrophy” and attention erosion, and warns of a widening cognitive divide and rising pressures on information verification and trust.
Jan.21 by 2FIRSTS.ai
Russia’s Public Chamber official opposes “generational ban” on tobacco sales, citing rights concerns
Russia’s Public Chamber official opposes “generational ban” on tobacco sales, citing rights concerns
Vladislav Grib, deputy secretary of the Public Chamber of the Russian Federation, said a “generational ban” on cigarette sales—restricting sales based on year of birth—would not resolve smoking and would instead lead to human rights violations. He argued older cohorts would buy and share, and the approach would split citizens into two categories.
Jan.08 by 2FIRSTS.ai
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
British American Tobacco (BAT) CEO Tadeu Marroco said the group will continue to invest in equipment and technology in Italy and expand capacity for next-generation tobacco products such as e-cigarettes and heated tobacco. BAT’s Trieste innovation hub is slated to receive a total investment of 500 million euros by 2027 and add 16 new production lines.
Feb.03 by 2FIRSTS.ai